Report

  • Home |
  • Reports |
  • Global Veterinary Oncology Market by Product Type (Felines and Canines, Equines,....
src

Global Veterinary Oncology Market by Product Type (Felines and Canines, Equines, and Livestock Animals) and by End-Users/Application (Canine Lymphoma, Osteosarcoma, Mast Cell Cancer, Melanoma and Multiple Myeloma) Global Market Share, Forecast Data, In-Depth Analysis, and Detailed Overview, and Forecast, 2020 - 2027

 Report Code
 Category
 Published Date
 Pages
 Format
PM-1252
Medical Devices
13 April 2020
203
PDF
Press Release

The report on the global veterinary oncology market analyzes complete scenario i.e., existing as well as future visions of recovered veterinary oncology market. It includes detailed overview of veterinary oncology market along with market pictures. Additionally, report has included complete data of the various segments in the global recovered veterinary oncology market followed by its applications, end users and region wide segmentation. Moreover, report has highlights of global key players present in this market. Top global players are analyzed completely along with their financials, technological innovations, key developments, apart from future strategies, SWOT analysis, acquisitions & mergers, and market footprint.

Global veterinary oncology market report offers in-depth insights, revenue details, and other vital information regarding the global veterinary oncology market, and the various trends, drivers, restraints, opportunities, and threats in the target market till year 2027. Hence, it covers the impact of these drivers and restraints on demand for this market during the forecast period. The report also includes PEST analysis, Porter’s Five Forces analysis, and opportunity map analysis for in-depth understanding of the market.

It provides historical data along with future forecast as well as detailed analysis of market on a global, regional and country level. Important market data of this market is projected in the form of form of tables, graphics, and pictures. On a regional basis, the market is categorized into five regions that include North America, Europe, Asia Pacific, Latin America, and Middle & East Africa. It analyzes complete scenario of each and every region along with highest share holder of veterinary oncology market.

Market Segmentation:
Segmentation by Type Felines and Canines
Equines
Livestock Animals
Segmentation by Application Canine Lymphoma 
Osteosarcoma 
Mast Cell Cancer 
Melanoma 
Multiple Myeloma
Market, By Regions North America (the United States, Canada, and Mexico)
Europe (Germany, UK, France, Italy, and Russia, etc.)
Asia-Pacific (China, Japan, ASEAN, India, and Korea)
The Middle East and Africa (UAE, Egypt, South Africa, Saudi Arabia)
South America (Brazil, Chile, Peru, and Argentina)

In addition, veterinary oncology market report sorted and categorized the information and data according to the major geographical regions which are expected to impact on the industry in forecast period.

Report also provides factors that are contributing to and influencing the expansion of the global veterinary oncology   market. It projects the market assessment for the predicted time. Along with all these report includes the manufacturing process along with shipment, price, revenue, gross profit, potential, interview records, business distribution, etc. This enables users to get complete scenario of competitive analysis of the market.

Pivotal Fundamentals of the Global Veterinary Oncology Market Report:
  • Holistic in-depth detailed analysis, regarding the parent market.
  • Detailed information about the current R&D activities performed by each veterinary oncology     market player.
  • Region-wise and country-wise breakdown of the veterinary oncology     market to get the revenue, and growth lookout in these areas.
  • Key factors which are influencing the consumption pattern of consumers across various regions and countries.
  • Historical and future progress of the global veterinary oncology market.
  • Year-on-year growth of the global recovered veterinary oncology market in terms of value and volume.
Conclusion:
At last report covers a short outline of the dealers, distributors, and suppliers. Additionally, it provides sales channel, analysis findings and results. It spots some new entrants within the market. The study thus, suggests a brand new proposition to embellish recovered veterinary oncology market and nurture business as it explains current global market as well as future market.
 

Chapter 1 Veterinary Oncology Market Overview
1.1 Product Overview and Scope of Veterinary Oncology 

Chapter 2 Executive Summary 
2.1 Drivers for Veterinary Oncology market:
2.2 Restrain for Veterinary Oncology market:
2.3 Opportunity for Veterinary Oncology market:
2.4 Global Veterinary Oncology market, 2015 - 2027
2.5 Global Veterinary Oncology market, by Region, 2015 - 2027
2.6 Global Veterinary Oncology market, by Type, 2015 - 2027
2.7 Global Veterinary Oncology market, by Application, 2015 - 2027

Chapter 3 Veterinary Oncology Segment by Types (Product Category) 
3.1 Global Veterinary Oncology Revenue (USD Million) and Growth Rate (%) Comparison by Types (2015-2020)
3.2 Global Veterinary Oncology Revenue Market Share (%) by Types in 2019
3.3 Felines and Canines
3.4 Equines
3.5 Livestock Animal

Chapter 4 Global Veterinary Oncology Segment by Application 
4.1 Global Veterinary Oncology Revenue (USD Million) Comparison by Application (2015-2027)
4.2 Canine Lymphoma 
4.3 Osteosarcoma
4.4 Mast Cell Cancer
4.5 Melanoma
4.6 Multiple Myeloma

Chapter 5 Global Veterinary Oncology Market by Regions (2015-2027) 
5.1 Global Veterinary Oncology Market Size and Growth Rate (%) Comparison by Regions (2015-2027)
5.2 North America Veterinary Oncology Status and Prospect (2015-2027)
5.3 Europe Veterinary Oncology Status and Prospect (2015-2027) 
5.4 Asia Pacific Veterinary Oncology Status and Prospect (2015-2027) 
5.5 South America Veterinary Oncology Status and Prospect (2015-2027)
5.6 Middle East & Africa Veterinary Oncology Status and Prospect (2015-2027)
5.7 Global Veterinary Oncology Market Size (2015-2027)
            5.7.1 Global Veterinary Oncology Revenue Status and Outlook (2015-2027)
            
Chapter 6 Global Veterinary Oncology Market Competition by Manufacturers
6.1 Global Veterinary Oncology Revenue and Share by Manufacturers (2015-2019)

Chapter 7 Company (Top Players) Profiles and Key Data
7.1 Zoetis Inc. 
            7.1.1 Company basic information and sales area
            7.1.2 Business Segment/ Overview
            7.1.3 Investment in Research and Development
            7.1.4 Veterinary Oncology Product Types Specification
            7.1.5 Key Developments
            7.1.6 Business Strategy
7.2 Elanco
            7.2.1 Company basic information and sales area
            7.2.2 Business Segment/ Overview
            7.2.3 Investment in Research and Development
            7.2.4 Veterinary Oncology Product Types Specification
            7.2.5 Business Strategy
7.3 AB Science
            7.3.1 Company basic information, and sales area
            7.3.2 Business Segment/ Overview
            7.3.3 Veterinary Oncology Product Types Specification
            7.3.4 Key Developments
            7.3.5 Business Strategy
7.4 Boehringer Ingelheim International GmbH
            7.4.1 Company basic information and sales area.
            7.4.2 Business Segment/ Overview
            7.4.3 Veterinary Oncology Product Types Specification
            7.4.4 Business Strategy
7.5 Zenoaq
            7.5.1 Company basic information and sales area.
            7.5.2 Business Segment/ Overview
            7.5.3 Veterinary Oncology Product Types Specification
            7.5.4 Business Strategy
7.6 VetDC
            7.6.1 Company basic information, and sales area
            7.6.2 Business Segment/ Overview
            7.6.3 Veterinary Oncology Product Types Specification
            7.6.4 Business Strategy
7.7 Morphogenesis, Inc.
            7.7.1 Company basic information, and sales area
            7.7.2 Business Segment/ Overview
            7.7.3 Investment in Research and Development
            7.7.4 Veterinary Oncology Product Types Specification
            7.7.5 Key Developments
            7.7.6 Business Strategy
7.8 Karyopharm Therapeutics, Inc.
            7.8.1 Company basic information and sales area.
            7.8.2 Business Segment/ Overview
            7.8.3 Veterinary Oncology Product Types Specification
            7.8.4 Business Strategy
7.9 Regeneus Ltd.
            7.9.1 Company basic information and sales area
            7.9.2 Business Segment/ Overview
            7.9.3 Veterinary Oncology Product Types Specification
            7.9.4 Business Strategy
7.10 AdvaVet, Inc. 
            7.10.1 Company basic information, and sales area
            7.10.2 Business Segment/ Overview
            7.10.3 Veterinary Oncology Product Types Specification
            7.10.4 Business Strategy
            
Chapter 8 Global Veterinary Oncology Revenue by Regions (2015-2020)
8.1 Global Veterinary Oncology Revenue and Market Share (%) by Regions (2015-2020)

Chapter 9 Global Veterinary Oncology Revenue by Types
9.1 Global Veterinary Oncology Revenue and Market Share (%) by Types (2015-2020)

Chapter 10 Global Veterinary Oncology Market Analysis by Application
10.1 Global Veterinary Oncology Revenue (USD Million) and Market Share (%) by Application (2015-2020)
10.2 Global Veterinary Oncology Revenue Growth Rate by Application (2015-2020)

Chapter 11 North America Veterinary Oncology Market Development Status and Outlook
11.1 North America Veterinary Oncology Market Size (2015-2020)
            11.1.1 North America Veterinary Oncology Market Size by Type (USD Million) (2015-2020)
11.2 North America Veterinary Oncology Market Size (2015-2020)
            11.2.1 North America Veterinary Oncology Market Size by Application (USD Million) (2015-2020)
11.3 U.S
            11.3.1 U.S. Veterinary Oncology market, by Type, 2015 - 2027
            11.3.2 U.S. Veterinary Oncology market, by Application, 2015 – 2027
11.4 Canada
            11.4.1 Canada Veterinary Oncology market, by Type, 2015 - 2027
            11.4.2 Canada Veterinary Oncology market, by Application, 2015 – 2027
11.5 Mexico
            11.5.1 Mexico Veterinary Oncology market, by Type, 2015 - 2027
            11.5.2 Mexico Veterinary Oncology market, by Application, 2015 – 2027
            
Chapter 12 Europe Veterinary Oncology Market Development Status and Outlook
12.1 Europe Veterinary Oncology Market Size (2015-2020)
            12.1.1 Europe Veterinary Oncology Market Size by Type (USD Million) (2015-2020)
12.2 Europe Veterinary Oncology Market Size (2015-2020)
            12.2.1 Europe Veterinary Oncology Market Size by Application (USD Million) (2015-2020)
12.3 U.K.
            12.3.1 U.K. Veterinary Oncology market, by Type, 2015 - 2027
            12.3.2 U.K. Veterinary Oncology market, by Application, 2015 – 2027
12.4 Germany
            12.4.1 Germany Veterinary Oncology market, by Type, 2015 - 2027
            12.4.2 Germany Veterinary Oncology market, by Application, 2015 – 2027
12.5 France
            12.5.1 France Veterinary Oncology market, by Type, 2015 – 2027
            12.5.2 France Veterinary Oncology market, by Application, 2015 – 2027
12.6 Italy
            12.6.1 Italy Veterinary Oncology market, by Type, 2015 – 2027
            12.6.2 Italy Veterinary Oncology market, by Application, 2015 – 2027
12.7 Spain
            12.7.1 Spain Veterinary Oncology market, by Type, 2015 – 2027
            12.7.2 Spain Veterinary Oncology market, by Application, 2015 – 2027
12.8 Rest of Europe
            12.8.1 Rest of Europe Veterinary Oncology market, by Type, 2015 – 2027
            12.8.2 Rest of Europe Veterinary Oncology market, by Application, 2015 – 2027
            
Chapter 13 Asia Pacific Veterinary Oncology Market Development Status and Outlook
13.1 Asia Pacific Veterinary Oncology Market Size (2015-2020)
            13.1.1 Asia Pacific Veterinary Oncology Market Size by Type (USD Million) (2015-2020)
13.2 Asia Pacific Veterinary Oncology Market Size (2015-2020)
            13.2.1 Asia Pacific Veterinary Oncology Market Size by Application (USD Million) (2015-2020)
13.3 China
            13.3.1 China Veterinary Oncology market, by Type, 2015 – 2027
            13.3.2 China Veterinary Oncology market, by Application, 2015 – 2027
13.4 Japan
            13.4.1 Japan Veterinary Oncology market, by Type, 2015 – 2027
            13.4.2 Japan Veterinary Oncology market, by Application, 2015 – 2027
13.5 India
            13.5.1 India Veterinary Oncology market, by Type, 2015 – 2027
            13.5.2 India Veterinary Oncology market, by Application, 2015 – 2027
13.6 Southeast Asia
            13.6.1 Southeast Asia Veterinary Oncology market, by Type, 2015 – 2027
            13.6.2 Southeast Asia Veterinary Oncology market, by Application, 2015 – 2027
            
Chapter 14 South America Veterinary Oncology Market Development Status and Outlook
14.1 South America Veterinary Oncology Market Size (2015-2020)
            14.1.1 South America Veterinary Oncology Market Size by Type (USD Million) (2015-2020) 
14.2 South America Veterinary Oncology Market Size (2015-2020)
            14.2.1 South America Veterinary Oncology Market Size by Application (USD Million) (2015-2020)
14.3 Brazil
            14.3.1 Brazil Veterinary Oncology market, by Type, 2015 – 2027
            14.3.2 Brazil Veterinary Oncology market, by Application, 2015 – 2027
14.4 Argentina
            14.4.1 Argentina Veterinary Oncology market, by Type, 2015 – 2027
            14.4.2 Argentina Veterinary Oncology market, by Application, 2015 – 2027 
14.5 Colombia
            14.5.1 Colombia Veterinary Oncology market, by Type, 2015 – 2027
            14.5.2 Colombia Veterinary Oncology market, by Application, 2015 – 2027
14.6 Rest of South America
            14.6.1 Colombia Veterinary Oncology market, by Type, 2015 – 2027
            14.6.2 Colombia Veterinary Oncology market, by Application, 2015 – 2027
            
Chapter 15 Middle East & Africa Veterinary Oncology Market Development Status and Outlook
15.1 Middle East & Africa Veterinary Oncology Market Size (2015-2020)
            15.1.1 Middle East & Africa Veterinary Oncology Market Size by Type (USD Million) (2015-2020)
15.2 Middle East & Africa Veterinary Oncology Market Size (2015-2020)
            15.2.1 Middle East & Africa Veterinary Oncology Market Size by Application (2015-2020)
15.3 UAE
            15.3.1 UAE Veterinary Oncology market, by Type, 2015 – 2027
            15.3.2 UAE Veterinary Oncology market, by Application, 2015 – 2027
15.4 South Africa
            15.4.1 South Africa Veterinary Oncology market, by Type, 2015 – 2027
            15.4.2 South Africa Veterinary Oncology market, by Application, 2015 – 2027
15.5 Egypt
            15.5.1 Egypt Veterinary Oncology market, by Type, 2015 – 2027
            15.5.2 Egypt Veterinary Oncology market, by Application, 2015 – 2027
15.6 Rest of MEA
            15.6.1 Rest of MEA Veterinary Oncology market, by Type, 2015 – 2027
            15.6.2 Rest of MEA Veterinary Oncology market, by Application, 2015 – 2027
            
Chapter 16 Veterinary Oncology Manufacturing Cost Analysis
16.1 Proportion of Manufacturing Cost Structure
            16.1.1 Raw Materials
            16.1.2 Labor Cost
            16.1.3 USA Labor Cost Analysis
            16.1.4 EU Labor Costs Analysis
            16.1.5 China Labor Costs Analysis
            16.1.6 Manufacturing Expenses
            
Chapter 17 Marketing Strategy Analysis, Distributors/Traders
17.1 Marketing Channel
            17.1.1 Direct Marketing
            17.1.2 Indirect Marketing
            17.1.3 Marketing Channel Development Trend
17.2 Market Positioning
            17.2.1 Pricing Strategy
            
Chapter 18 Global Veterinary Oncology Market Forecast (2020-2027)
18.1 Global Veterinary Oncology Revenue Forecast (2020-2027)
            18.1.1 Global Veterinary Oncology Revenue (USD Million) and Growth Rate (%) Forecast (2020-2027)
18.2 Global Veterinary Oncology Revenue (USD Million) Forecast by Regions (2020-2027)
            18.2.1 North America Veterinary Oncology Revenue (USD Million) Forecast (2020-2027)
            18.2.2 Europe Veterinary Oncology Revenue (USD Million) Forecast (2020-2027)
            18.2.3 Asia Pacific Veterinary Oncology and Revenue (USD Million) Forecast (2020-2027)
            18.2.4 South America Veterinary Oncology and Revenue (USD Million) Forecast (2020-2027)
            18.2.5 Middle East & Africa Veterinary Oncology and Revenue (USD Million) Forecast (2020-2027)
18.3 Global Veterinary Oncology Revenue Forecast by Type (2020-2027)
18.4 Global Veterinary Oncology Revenue (USD Million) Forecast by Application (2020-2027)

Chapter 19 North America Veterinary Oncology Market Development Status and Outlook
19.1 North America Veterinary Oncology Market Size (2020-2027)
            19.1.1 North America Veterinary Oncology Market Size by Type (USD Million) (2020-2027)
19.2 North America Veterinary Oncology Market Size (2020-2027)
            19.2.1 North America Veterinary Oncology Market Size by Application (USD Million) (2020-2027)
19.3 U.S.
            19.3.1 U.S. Veterinary Oncology market, by Type, 2020 – 2027
            19.3.2 U.S. Veterinary Oncology market, by Application, 2020 – 2027
19.4 Canada
            19.4.1 Canada Veterinary Oncology market, by Type, 2020 – 2027
            19.4.2 Canada Veterinary Oncology market, by Application, 2020 – 2027
19.5 Mexico
            19.5.1 Mexico Veterinary Oncology market, by Type, 2020 – 2027
            19.5.2 Mexico Veterinary Oncology market, by Application, 2020 – 2027
            
Chapter 20 Europe Veterinary Oncology Market Development Status and Outlook
20.1 Europe Veterinary Oncology Market Size (2020-2027)
            20.1.1 Europe Veterinary Oncology Market Size by Type (USD Million) (2020-2027)
20.2 Europe Veterinary Oncology Market Size (2020-2027)
            20.2.1 Europe Veterinary Oncology Market Size by Application (USD Million) (2020-2027)
20.3 U.K.
            20.3.1 U.K. Veterinary Oncology market, by Type, 2020 – 2027
            20.3.2 U.K. Veterinary Oncology market, by Application, 2020 – 2027
20.4 Germany
            20.4.1 Germany Veterinary Oncology market, by Type, 2020 – 2027
            20.4.2 Germany Veterinary Oncology market, by Application, 2020 – 2027
20.5 France
            20.5.1 France Veterinary Oncology market, by Type, 2020 – 2027
            20.5.2 France Veterinary Oncology market, by Application, 2020 – 2027
20.6 Italy
            20.6.1 France Veterinary Oncology market, by Type, 2020 – 2027
            20.6.2 France Veterinary Oncology market, by Application, 2020 – 2027
20.7 Spain
            20.7.1 France Veterinary Oncology market, by Type, 2020 – 2027
            20.7.2 France Veterinary Oncology market, by Application, 2020 – 2027
20.8 Rest of Europe
            20.8.1 France Veterinary Oncology market, by Type, 2020 – 2027
            20.8.2 France Veterinary Oncology market, by Application, 2020 – 2027
            
Chapter 21 Asia Pacific Veterinary Oncology Market Development Status and Outlook
21.1 Asia PacificVeterinary Oncology Market Size (2020-2027)
            21.1.1 Asia Pacific Veterinary Oncology Market Size by Type (USD Million) (2020-2027)
21.2 Asia PacificVeterinary Oncology Market Size (2020-2027)
            21.2.1 Asia Pacific Veterinary Oncology Market Size by Application (USD Million) (2020-2027)
21.3 China
            21.3.1 China Veterinary Oncology market, by Type, 2020 – 2027
            21.3.2 China Veterinary Oncology market, by Application, 2020 – 2027
21.4 Japan
            21.4.1 Japan Veterinary Oncology market, by Type, 2020 – 2027
            21.4.2 Japan Veterinary Oncology market, by Application, 2020 – 2027
21.5 India
            21.5.1 India Veterinary Oncology market, by Type, 2020 – 2027
            21.5.2 India Veterinary Oncology market, by Application, 2020 – 2027
21.6 Southeast Asia
            21.6.1 Southeast Asia Veterinary Oncology market, by Type, 2020 – 2027
            21.6.2 Southeast Asia Veterinary Oncology market, by Application, 2020 – 2027
            
Chapter 22 South America Veterinary Oncology Market Development Status and Outlook
22.1 South America Veterinary Oncology Market Size (2020-2027)
            22.1.1 South America Veterinary Oncology Market Size by Type (USD Million) (2020-2027)
22.2 South America Veterinary Oncology Market Size (2020-2027)
            22.2.1 South America Veterinary Oncology Market Size by Application (USD Million) (2020-2027)
22.3 Brazil
            22.3.1 Brazil Veterinary Oncology market, by Type, 2020 – 2027
            22.3.2 Brazil Veterinary Oncology market, by Application, 2020 – 2027 
22.4 Argentina
            22.4.1 Argentina Veterinary Oncology market, by Type, 2020 – 2027
            22.4.2 Argentina Veterinary Oncology market, by Application, 2020 – 2027 
22.5 Colombia
            22.5.1 Colombia Veterinary Oncology market, by Type, 2020 – 2027
            22.5.2 Colombia Veterinary Oncology market, by Application, 2020 – 2027
22.6 Rest of South America
            22.6.1 Colombia Veterinary Oncology market, by Type, 2020 – 2027
            22.6.2 Colombia Veterinary Oncology market, by Application, 2020 – 2027
            
Chapter 23 Middle East & Africa Veterinary Oncology Market Development Status and Outlook
23.1 Middle East & Africa Veterinary Oncology Market Size (2020-2027)
            23.1.1 Middle East & Africa Veterinary Oncology Market Size by Type (USD Million) (2020-2027)
23.2 Middle East & Africa Veterinary Oncology Market Size (2020-2027)
            23.2.1 Middle East & Africa Veterinary Oncology Market Size by Application (USD Million) (2020-2027)
23.3 UAE
            23.3.1 UAE Veterinary Oncology market, by Type, 2020 – 2027
            23.3.2 UAE Veterinary Oncology market, by Application, 2020 – 2027
23.4 South Africa
            23.4.1 South Africa Veterinary Oncology market, by Type, 2020 – 2027
            23.4.2 South Africa Veterinary Oncology market, by Application, 2020 – 2027
23.5 Egypt
            23.5.1 Egypt Veterinary Oncology market, by Type, 2020 – 2027
            23.5.2 Egypt Veterinary Oncology market, by Application, 2020 – 2027
24.6 Rest of MEA
            24.6.1 Rest of MEA Veterinary Oncology market, by Type, 2020 – 2027
            24.6.2 Rest of MEA Veterinary Oncology market, by Application, 2020 – 2027
            
Chapter 25 Research Findings and Conclusion
 

No Methodology

Global Veterinary Oncology Market Trends:
The global veterinary oncology is estimated to be worth USD 197.22 million in 2019 and is projected to reach USD 757.61 million by 2027, at a CAGR of 10.8% from 2020 to 2027.

Veterinary oncology is a specialty of veterinary medicine that deals with cancer diagnosis and treatment in animals. Cancer is a major cause of death in pet animals. In the past few decades, there has been an increased prevalence of cancer in animals, which is one of the major aspects for the growth of the veterinary oncology market. In addition, increased healthcare facilities for the animals and increased pet healthcare expenditure are one of the major aspects which propel the growth of the market for the estimated forecasts period. However, lack of awareness of pet diseases among the pet owners is one of the major aspects which hinder the growth of the market.

Global Veterinary Oncology Market, By Type:
Based on the types, it can be segmented into felines and canines, equines and livestock animals. Based on its types, felines and canines accounted for the largest share in the estimated forecasts period. It can be attributed to increased adoption of cats and dogs. Moreover, these animals are more susceptible to the diseases, thereby boosting the growth of the market for the estimated forecasts period.

Global Veterinary Oncology, By Application:
Based on applications, it can be segmented into canine lymphoma, osteosarcoma, mast cell cancer, melanoma, and multiple myeloma. Based on its application, canine lymphoma accounted for the largest share of the market for the estimated forecasts period. This can be attributed to the increased occurrence of lymphoma in canines, which is one of the major aspects which boost the growth of the market for the estimated forecasts period. Moreover, rise in demand for the medicines for the canine lymphoma is one of the major aspects, which contributes to the growth of the market for the estimated forecasts period.

Global Veterinary Oncology Market, By Region:
Report covers the region wise analysis; global veterinary oncology can be segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Among all, North America has the largest segment, which can be attributed to the largest share in the market. This can be attributed to the increased to the increased adoption of pets and increased demand for the pet insurance among the pet owners is one of the major factor which attributes to the growth of the market for the estimated forecasts period. Moreover, increased adoption of new techniques in treatment of pets is also one of the major factors for the growth of the veterinary oncology devices market in the estimated forecasts period.

Major Market Players:
Some of the major players in the market are Zoetis Inc., Elanco, AB Science, Boehringer  Ingelheim International GmbH, Zenoaq, VetDC, Morphogenesis, Inc., Karyopharm Therapeutics, Inc., Regeneus Ltd., and AdvaVet, Inc. In June 2018, Zoetis Inc. has ventured into five year collaboration with Regeneron Pharmaceuticals, Inc. Under this agreement, Regeneron has granted Zoetis a license for its VelocImmune antibody technology. This will be used by Zoetis to determine therapies for diseases such as cancer, allergic and immune-related conditions in animals.

Global Veterinary Oncology Market Report Scope:
Report Parameters Details of Parameter
Market Size 2015-2027
Based Year 2019
Forecast Period Covered 2020-2027
Units for value USD (Million)
Covered Segments Product Type, Applications, Geographic Regions
Product Type Felines and Canines, Equines, and Livestock Animals
Applications Canine Lymphoma, Osteosarcoma, Mast Cell Cancer, Melanoma and Multiple Myeloma
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Covered Zoetis Inc., Elanco, AB Science, Boehringer  Ingelheim International GmbH, Zenoaq, VetDC, Morphogenesis, Inc., Karyopharm Therapeutics, Inc., Regeneus Ltd., and AdvaVet, Inc

The report analyzes all the factors which are impacting on the market and on that basis describes the drivers, restraints, and opportunities for the growth of the global veterinary oncology market. Similarly, report provides the all the segmentations along with the qualitative analysis.
 
Global Veterinary Oncology Market: Product analysis
      •  Felines and Canines
      •  Equines
      •  Livestock Animals

Global Veterinary Oncology Market: Application analysis
  • Canine Lymphoma
  • Osteosarcoma
  • Mast Cell Cancer
  • Melanoma
  • Multiple Myeloma
Market, By Regions:
In addition, veterinary oncology report sorted and categorized the information and data according to the major geographical regions which are expected to impact on the industry in forecast period. Following are the regions we covered in this report:
  • North America (U.S., Canada, Mexico)
  • Europe (U.K., France, Germany, Spain, Italy, Central & Eastern Europe, CIS)
  • Asia Pacific (China, Japan, South Korea, ASEAN, India, Rest of Asia Pacific)
  • Latin America (Brazil, Rest of L.A.)
  • Middle East and Africa (Turkey, GCC, Rest of Middle East)
 
 
 

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase